Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Carisma Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230321144A1 | Application | Modified immune cells for fibrosis and inflammation | C12N15/86; C12N9/64; C12Y304/24035; A01K2207/15; A01K2217/072; A01K2227/105; A01K2267/0368; A61K35/15; A61K38/2066; A61P29/00; C07K14/521; C07K14/5428 | October 12, 2023 |
| IL304559A | Application | Self-polarizing immune cells | C12N2510/00; C12N5/0645; A61K35/15; A61K35/17; A61K35/545; C07K14/52; C07K14/7051; C07K14/715; C07K2319/02; C07K2319/50 | September 01, 2023 |
| US11739297B2 | Grant | Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor | C12N15/1138; C12N15/86; C12N2310/20; C12N2501/24; C12N2501/515; C12N2501/52; C12N2501/599; C12N2510/00; C12N2740/15043; C12N2740/16043; C12N5/0645; A61K2039/5156; A61K2039/5158; A61K35/15; A61K38/00; A61K39/0011; A61P35/00; C07K14/4703; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/70535; C07K14/70596; C07K16/00; C07K16/2896; C07K16/32; C07K2317/53; C07K2317/622; C07K2317/73; C07K2317/76; C07K2319/00; C07K2319/02; C07K2319/03; C07K2319/30; C07K2319/33 | August 29, 2023 |
| WO2023107593A3 | Application | In vivo delivery to immune cells | C07K14/7051; C07K2319/03; A61K39/4631; A61K39/4611 | July 27, 2023 |
| US20230235286A1 | Application | Mrna transfection of immune cells | C12N15/101; C12N15/87; C12N2501/24; C12N2501/515; C12N2501/65; C12N2501/999; C12N2510/00; C12N5/0645; A61K2039/5156; A61K2039/53; A61K31/404; A61K35/15; A61K39/4631; A61K39/4644; A61K2239/26; A61K39/4611 | July 27, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer